New Antibiotic After 30 Years Challenges Superbugs
- A potential weapon against antibiotic resistance, a major global health threat, has been discovered by canadian scientists.
- Published in the journal Nature, the findings highlight lariocidin's unique mechanism of action and its effectiveness against both resistant and non-resistant bacteria in initial laboratory tests.
- Lariocidin is produced by a type of soil bacterium known as Paenibacillus.
New Lasso-Shaped Antibiotic Shows Promise Against Drug-Resistant Bacteria
Table of Contents
- New Lasso-Shaped Antibiotic Shows Promise Against Drug-Resistant Bacteria
- New Lasso-Shaped Antibiotic Shows Promise Against Drug-Resistant Bacteria: Your Top Questions Answered
- What is antibiotic Resistance, and Why Should We Care?
- What is Lariocidin, and How Does it Work?
- How Effective is Lariocidin Against Resistant bacteria?
- Where Did Lariocidin Come From?
- What Are the Current Challenges in Combating Antibiotic Resistance?
- What Are the Statistics Related to Antibiotic Resistance?
- What Are the Next Steps for Lariocidin?
- Comparison of Lariocidin with Existing Antibiotics
A potential weapon against antibiotic resistance, a major global health threat, has been discovered by canadian scientists. Researchers have identified a microorganism that naturally produces a novel antibiotic called lariocidin.
Published in the journal Nature, the findings highlight lariocidin’s unique mechanism of action and its effectiveness against both resistant and non-resistant bacteria in initial laboratory tests.
Lariocidin: A New Approach
Lariocidin is produced by a type of soil bacterium known as Paenibacillus. According to researchers, this molecule, a peptide, demonstrates potential in combating some of the most resistant bacteria. Unlike existing antibiotics, lariocidin directly targets the protein synthesis machinery within infectious agents, inhibiting their growth and survival.
Addressing a Critical Need
The discovery addresses the urgent need for new antimicrobial drugs as bacteria and other microorganisms develop resistance to existing treatments. This phenomenon, known as antimicrobial resistance (AMR), is identified by the World Health Organization (WHO) as a significant threat to global public health.
Manoj Jangra, a postdoctoral fellow at mcmaster University, said in a video interview that Lariocidin is effective against multidrug-resistant bacteria that pose a significant threat to society.
A recent WHO report indicates that while 32 antibiotics are currently in growth worldwide, only 12 are considered innovative.Furthermore, only four of these are active against at least one “critical” pathogen, as defined by the WHO’s list of antibiotic-resistant threats.
Data indicates that antibiotic resistance rates are exceeding 30%, particularly among pathogens responsible for over 35,000 deaths annually in Europe.
Every year around 4.5 million people die due to antibiotic resistant infections and the situation only worsens.
Discovery Process and Future Development
The research team cultivated bacteria collected from the soil in a laboratory setting,enabling the identification of slow-growing species that might otherwise have been missed. One of these bacteria, Paenibacillus, produced lariocidin, which exhibited strong activity against other bacteria, including those resistant to existing antibiotics.
lariocidin is not susceptible to current antibiotic resistance mechanisms and has shown effectiveness in animal models of infection.
The next step involves producing the molecule in sufficient quantities to facilitate clinical development.
Researchers caution that significant time and resources will be required before lariocidin is ready for market.
New Lasso-Shaped Antibiotic Shows Promise Against Drug-Resistant Bacteria: Your Top Questions Answered
What is antibiotic Resistance, and Why Should We Care?
Antibiotic resistance occurs when bacteria evolve to survive the effects of antibiotics, making infections harder to treat. The World Health Organization (WHO) identifies antimicrobial resistance (AMR) as a major global health threat. The implications are severe,perhaps leading to:
Increased illness and death: Infections that were once easily treated can become life-threatening.
Higher healthcare costs: Treating resistant infections requires more expensive and complex treatments.
Limited treatment options: As resistance grows, the effectiveness of existing antibiotics decreases.
What is Lariocidin, and How Does it Work?
Lariocidin is a novel antibiotic discovered by Canadian scientists. This molecule, a peptide, is produced by the soil bacterium paenibacillus. Unlike existing antibiotics, Lariocidin directly targets the protein synthesis machinery within infectious agents, which inhibits their growth and survival.
How Effective is Lariocidin Against Resistant bacteria?
Initial laboratory tests have shown Lariocidin’s effectiveness against both resistant and non-resistant bacteria. According to Manoj Jangra, a postdoctoral fellow at McMaster University, Lariocidin is effective against multidrug-resistant bacteria, which pose a meaningful threat.
Where Did Lariocidin Come From?
The research team cultivated bacteria collected from soil in a laboratory setting, which allowed the identification of slow-growing species. The Paenibacillus bacterium was found to produce Lariocidin.
What Are the Current Challenges in Combating Antibiotic Resistance?
Currently, the development of new antibiotics is lagging behind the rate at which bacteria are developing resistance. While 32 antibiotics are currently in development worldwide, only 12 are considered innovative. Furthermore, only four of these are active against at least one “critical” pathogen as defined by the WHO’s list of antibiotic-resistant threats. Data indicates that antibiotic resistance rates are exceeding 30%, notably among pathogens.
The situation is dire, wiht an increasing number of deaths each year:
Every year, around 4.5 million people die due to antibiotic-resistant infections.
Antibiotic resistance rates are exceeding 30%, particularly among pathogens responsible for over 35,000 deaths annually in Europe.
What Are the Next Steps for Lariocidin?
Researchers are now focused on:
Producing Lariocidin in sufficient quantities for clinical development.
Conducting further tests and trials before Lariocidin is ready for market.
Significant time and resources will be required before Lariocidin becomes available for widespread use.
Comparison of Lariocidin with Existing Antibiotics
| Feature | Lariocidin | Existing Antibiotics |
| ——————— | ——————————————– | ——————————————————– |
| Production source | Soil bacterium Paenibacillus* | Varying |
| Mechanism of Action | Targets protein synthesis machinery | Varies |
| Resistance | Not susceptible to current resistance mechanisms | Bacteria have developed resistance to many existing antibiotics |
| Stage of Development | early-stage research; in testing | Widely available, but with increasing resistance |